As the role of SIRT1-mediated autophagy in metabolic disorders have been increasingly highlighted, clinical and animal studies have been conducted to validate the use potential SIRT1 modulator as a therapeutic intervention for endocrine disorders by targeting SIRT1-autophagy axis. Here, SIRT1 is linked to endocrine system disorder.